Clinical trial
A Clinical Trial Assessing The Impact Of Inhaled Insulin On Glucose Control In…
NCT00282971 · Pfizer, Industry · Terminated
Key facts
| NCT number | NCT00282971 |
|---|---|
| Title | A Clinical Trial Assessing The Impact Of Inhaled Insulin On Glucose Control In Patients With Type 2 Diabetes Mellitus |
| Official title | A Six Month, Open-label Outpatient, Parallel Group Trial Assessing The Impact Of Inhaled Insulin (Exubera(Registered)) On Glycemic Control In Patients With Type 2 Diabetes Mellitus Who Are Poorly Controlled On Two Oral Anti-diabetic Agents |
| Lead sponsor | Pfizer, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus Type 2 |
| Intervention type | Drug, Other |
| Interventions | Inhaled Insulin (Exubera), Standard of Care |
| Enrollment | 354 |
| Start date | Mar 6, 2006 |
| Primary completion | Feb 19, 2008 |
| Completion | Feb 19, 2008 |
| First posted | Jan 27, 2006 |
| Last update posted | Apr 2, 2019 |
| Countries | Canada, France, Greece, Portugal, Spain, Sweden, Turkey (Türkiye) |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: